High-dose chemotherapy and autologous stem cell transplantation of patients with multiple myeloma in an outpatient setting

BACKGROUND: High-dose (HD) chemotherapy with melphalan and autologous blood stem cell transplantation (ABSCT) for treatment of symptomatic multiple myeloma (MM) on an outpatient basis has been well established in the USA and Canada, whereas in Germany and Western Europe an inpatient setting is the c...

Descripción completa

Detalles Bibliográficos
Autores principales: Lisenko, Katharina, Sauer, Sandra, Bruckner, Thomas, Egerer, Gerlinde, Goldschmidt, Hartmut, Hillengass, Jens, Schmier, Johann W., Shah, Sofia, Witzens-Harig, Mathias, Ho, Anthony D., Wuchter, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322605/
https://www.ncbi.nlm.nih.gov/pubmed/28228122
http://dx.doi.org/10.1186/s12885-017-3137-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322605/
https://www.ncbi.nlm.nih.gov/pubmed/28228122
http://dx.doi.org/10.1186/s12885-017-3137-4

Ejemplares similares